581 related articles for article (PubMed ID: 33967773)
21. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome.
Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
Crit Care Med; 1997 Nov; 25(11):1820-6. PubMed ID: 9366764
[TBL] [Abstract][Full Text] [Related]
22. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China.
Zou Y; Guo H; Zhang Y; Zhang Z; Liu Y; Wang J; Lu H; Qian Z
Biosci Trends; 2020 Sep; 14(4):285-289. PubMed ID: 32350161
[TBL] [Abstract][Full Text] [Related]
23. Vitamin C for COVID-19 Treatment: Have We Got Enough Evidence?
Ahmad SR
Front Nutr; 2022; 9():892561. PubMed ID: 35662927
[No Abstract] [Full Text] [Related]
24. Dietary Supplements for COVID-19.
Mullin GE; Limektkai B; Wang L; Hanaway P; Marks L; Giovannucci E
Adv Exp Med Biol; 2021; 1318():499-515. PubMed ID: 33973197
[TBL] [Abstract][Full Text] [Related]
25. High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: A protocol for systematic review and meta-analysis.
Huang L; Wang L; Tan J; Liu H; Ni Y
Medicine (Baltimore); 2021 May; 100(19):e25876. PubMed ID: 34106642
[TBL] [Abstract][Full Text] [Related]
26. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
Med Clin (Barc); 2022 Apr; 158(8):356-360. PubMed ID: 34103164
[TBL] [Abstract][Full Text] [Related]
27. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial.
Mahmud R; Rahman MM; Alam I; Ahmed KGU; Kabir AKMH; Sayeed SKJB; Rassel MA; Monayem FB; Islam MS; Islam MM; Barshan AD; Hoque MM; Mallik MU; Yusuf MA; Hossain MZ
J Int Med Res; 2021 May; 49(5):3000605211013550. PubMed ID: 33983065
[TBL] [Abstract][Full Text] [Related]
28. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection.
Li M; Ching TH; Hipple C; Lopez R; Sahibzada A; Rahman H
J Pharm Pract; 2023 Feb; 36(1):60-66. PubMed ID: 34098784
[TBL] [Abstract][Full Text] [Related]
29. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease.
Lakkireddy M; Gadiga SG; Malathi RD; Karra ML; Raju ISSVPM; Ragini ; Chinapaka S; Baba KSSS; Kandakatla M
Sci Rep; 2021 May; 11(1):10641. PubMed ID: 34017029
[TBL] [Abstract][Full Text] [Related]
30. A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.
Sharma A; Shah M; Lakshmi S; Sane H; Captain J; Gokulchandran N; Khubchandani P; Pradeep MK; Gote P; Tuppekar B; Kulkarni P; Paranjape A; Pradhan R; Varghese R; Kasekar S; Nair V; Khanbande U
Int Immunopharmacol; 2021 Jul; 96():107743. PubMed ID: 33984718
[TBL] [Abstract][Full Text] [Related]
31. Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial.
Hemilä H; Carr A; Chalker E
Front Immunol; 2021; 12():674681. PubMed ID: 34040614
[No Abstract] [Full Text] [Related]
32. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study.
Liu J; Chen Y; Li R; Wu Z; Xu Q; Li Z; Annane D; Feng H; Huang S; Guo J; Zhang L; Ye X; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Teboul JL; Chen D
Clin Microbiol Infect; 2021 Oct; 27(10):1488-1493. PubMed ID: 34020032
[TBL] [Abstract][Full Text] [Related]
34. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease.
AlQahtani M; Abdulrahman A; Almadani A; Alali SY; Al Zamrooni AM; Hejab AH; Conroy RM; Wasif P; Otoom S; Atkin SL; Abduljalil M
Sci Rep; 2021 May; 11(1):9927. PubMed ID: 33976287
[TBL] [Abstract][Full Text] [Related]
35. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
Prats-Uribe A; Sena AG; Lai LYH; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Carter W; Casajust P; Dawoud D; Golozar A; Jonnagaddala J; Mehta PP; Gong M; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Shah K; Shah NH; Schilling LM; Subbian V; Vizcaya D; Zhang L; Zhang Y; Zhu H; Liu L; Cho J; Lynch KE; Matheny ME; You SC; Rijnbeek PR; Hripcsak G; Lane JC; Burn E; Reich C; Suchard MA; Duarte-Salles T; Kostka K; Ryan PB; Prieto-Alhambra D
BMJ; 2021 May; 373():n1038. PubMed ID: 33975825
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19.
Çolak Ş; Genç Yavuz B; Yavuz M; Özçelik B; Öner M; Özgültekin A; Şenbayrak S
Int J Clin Pract; 2021 Aug; 75(8):e14321. PubMed ID: 33971067
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area.
Meng Z; Wang T; Chen L; Chen X; Li L; Qin X; Li H; Luo J
Curr Top Med Chem; 2021; 21(10):920-927. PubMed ID: 33970846
[TBL] [Abstract][Full Text] [Related]
38. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.
Yong SJ
Infect Dis (Lond); 2021 Oct; 53(10):737-754. PubMed ID: 34024217
[TBL] [Abstract][Full Text] [Related]
39. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study.
Reis BZ; Fernandes AL; Sales LP; Santos MD; Dos Santos CC; Pinto AJ; Goessler KF; Franco AS; Duran CSC; Silva CBR; Macêdo MB; Dalmolin HHH; Baggio J; Balbi GGM; Antonangelo L; Caparbo VF; Gualano B; Murai IH; Pereira RMR
Am J Clin Nutr; 2021 Aug; 114(2):598-604. PubMed ID: 34020451
[TBL] [Abstract][Full Text] [Related]
40. Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection.
Davoudi A; Najafi N; Aarabi M; Tayebi A; Nikaeen R; Izadyar H; Salar Z; Delavarian L; Vaseghi N; Daftarian Z; Ahangarkani F
BMC Infect Dis; 2021 May; 21(1):450. PubMed ID: 34006228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
